|
Phase III Randomized Study of Adjuvant
Chemotherapy With or Without Bevacizumab in Patients With Completely
Resected Stage IB-IIIA Non-Small Cell Lung Cancer
(Bevacizumab Provided)
ECOG
E1505
(MBMC Contact: Chris Joyce 314-996-5536)
Click
For Consent
***
Phase III Randomized Study of Carboplatin
and Paclitaxel or Carboplatin, Paclitaxel, and Bevacizumab
With Versus Without Concurrent Cetuximab in Patients With
Stage IV or Recurrent Non-Small Cell Lung Cancer
SWOG
S0819
(MBMC Contact: Chris Joyce 314-996-5536)
Click
For Consent
***
Phase III Randomized Study of Sunitinib
Malate as Maintenance Therapy in Patients With Stage IIIB or
IV Non-Small Cell Lung Cancer Previously Treated With
Platinum-Based Combination Chemotherapy
(Sunitinib / Placebo Provided)
CALGB 30607
(MBMC Contact: Chris Joyce 314-996-5536)
Click
For Consent
***
***Available through CTSU
Lung Cancer Trials in St. Louis, MO
|